ASCVD MANAGEMENT
Clinical trials for ASCVD MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new ASCVD MANAGEMENT trials appear
Sign up with your email to follow new studies for ASCVD MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug calm heart inflammation in people with TET2 mutations?
Disease control Recruiting nowThis study tests whether canakinumab, an anti-inflammatory drug, can reduce blood vessel inflammation in people with coronary artery disease. Some participants have a genetic change called TET2 clonal hematopoiesis, which may increase inflammation. 120 adults will receive either …
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pill aims to unclog arteries in heart disease patients
Disease control Recruiting nowThis study tests a new daily pill called ABP-745 in 200 adults with atherosclerosis (hardening of the arteries from plaque buildup). Participants will take either a low, medium, or high dose of ABP-745 or a placebo for 52 weeks. The main goal is to see if the drug can reduce the …
Matched conditions: ASCVD MANAGEMENT
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Pharmacy interns take on cholesterol: a new way to fight heart disease?
Disease control Recruiting nowThis study tests whether pharmacy interns, working under supervision, can help people with heart disease lower their cholesterol. About 1,000 adults who are not meeting their LDL cholesterol goals will receive phone counseling from a student pharmacist. The goal is to see if this…
Matched conditions: ASCVD MANAGEMENT
Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC